Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AEHR TEST SYSTEMSAEHR · Entity 2640 | Director · President and CEO | October 12, 2026 | October 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AEHR TEST SYSTEMS
Report date October 12, 2026 · Filed October 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 191,108 |
Reported balance
After 2026-10-12 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-10-12 · Tax withholding · Disposed 2,675 · Balance 191,108 F1: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units and restricted shares. This does not represent a sale by the Reporting Person. F2: The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 158,776 |
Reported balance
Holding disclosure · report date 2026-10-12 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 158,776 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units and restricted shares. This does not represent a sale by the Reporting Person.
F2: The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 14, 2022 Filed Jul 18, 2022 20:02 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 36,630 | $8.00 | $293,040.00 |
DisclosureSEC source: 0001654954-22-009787 · section16.xml · nonDerivative · entry 3 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 675,524 F3 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of performance-based RSUs described in footnote 2. This does not represent a sale by the Reporting Person. F4 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| July 14, 2022 Filed Jul 18, 2022 20:02 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 68,988 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-22-009787 · section16.xml · nonDerivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 712,154 F2 · shares: Represents shares of common stock issued upon vesting of performance-based RSUs. Read SEC document |
| July 14, 2022 Filed Jul 18, 2022 20:02 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 82,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-22-009787 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 643,166 F1 · shares: One-sixteenth (1/16) of the total number of shares subject to the restricted stock unit awards shall become exercisable at the end of each three full calendar months following the date of this action, provided that such recipient is still employed by the corporation on such dates. Read SEC document |
| July 14, 2022 Filed Oct 20, 2022 20:09 UTC Amendment | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 36,630 | $8.00 | $293,040.00 |
DisclosureSEC source: 0001654954-22-013962 · section16.xml · nonDerivative · entry 3 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 675,524 F3 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of performance-based RSUs described in footnote 2. This does not represent a sale by the Reporting Person. F4 · balance_after: The amount reported includes shares subject to unvested restricted shares and restricted stock units. Read SEC document |
| July 14, 2022 Filed Oct 20, 2022 20:09 UTC Amendment | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 68,988 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-22-013962 · section16.xml · nonDerivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 712,154 F2 · shares: Represents shares of common stock issued upon vesting of performance-based RSUs. Read SEC document |
| July 14, 2022 Filed Oct 20, 2022 20:09 UTC Amendment | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 82,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-22-013962 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 643,166 F1 · shares: This report on Form 4/A is being filed to correct the footnote 1 on form 4 originally filed on July 18, 2022. The correct footnote should state: One-sixteenth (1/16) of the 75,000 of shares subject to the restricted stock unit awards shall become exercisable at the end of each three full calendar months following the date of this action, provided that such recipient is still employed by the corporation on such dates. One-sixteenth (1/16) of the 7,500 of shares subject to the restricted shares awards shall become exercisable at the end of each three full calendar months following the date of this action, provided that such recipient is still employed by the corporation on such dates. Read SEC document |
| July 13, 2022 Filed Jul 15, 2022 01:22 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 1,190 | $7.99 | $9,508.10 |
DisclosureSEC source: 0001654954-22-009726 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 562,689 F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. This does not represent a sale by the Reporting Person. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 01:47 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 27,610 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001654954-22-009263 · section16.xml · derivative · entry 4 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,610 shares Expires 2023-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 01:47 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 28,726 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001654954-22-009263 · section16.xml · derivative · entry 3 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,209 Underlying: Common Stock · 28,726 shares Expires 2026-07-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 01:47 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 28,726 | $1.64 | $46,967.01 |
DisclosureSEC source: 0001654954-22-009263 · section16.xml · nonDerivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 563,879 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 01:47 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 27,610 | $1.68 | $46,384.80 |
DisclosureSEC source: 0001654954-22-009263 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 535,153 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 20, 2022 Filed Apr 20, 2022 23:26 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 27,120 | $0.00 Strike: $2.10 | $0.00 |
DisclosureSEC source: 0001654954-22-005225 · section16.xml · derivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,120 shares Expires 2022-04-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| April 20, 2022 Filed Apr 20, 2022 23:26 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 27,120 | $2.10 | $56,952.00 |
DisclosureSEC source: 0001654954-22-005225 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 507,543 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| April 14, 2022 Filed Apr 15, 2022 01:04 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 2,083 | $8.99 | $18,726.17 |
DisclosureSEC source: 0001654954-22-005025 · section16.xml · nonDerivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 480,423 F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. This does not represent a sale by the Reporting Person. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| April 13, 2022 Filed Apr 15, 2022 01:04 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 1,258 | $9.41 | $11,837.78 |
DisclosureSEC source: 0001654954-22-005025 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 482,506 F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. This does not represent a sale by the Reporting Person. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 20:11 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 5,000 | $9.42 | $47,100.00 |
DisclosureSEC source: 0001654954-22-004763 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 483,764 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2021, as amended on February 11, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.21 to $9.73, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 01:03 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | OtherCommon Stock | 2,082 | $2.18 | $4,548.13 |
DisclosureSEC source: 0001654954-22-004572 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 488,764 F1 · shares: These shares have been purchased through the Company's Amended and Restated 2006 Employee Stock Purchase Plan, a "tax-conditioned plan" per Internal Revenue Code Section 423. This purchase is exempt from Section 16 of the Securities Exchange Act of 1934 regarding liabilities arising from six-month short-swing transactions in the Company's securities. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| January 14, 2022 Filed Jan 15, 2022 02:47 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 2,565 | $13.38 | $34,319.70 |
DisclosureSEC source: 0001654954-22-000543 · section16.xml · nonDerivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 486,682 F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. This does not represent a sale by the Reporting Person. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| January 13, 2022 Filed Jan 15, 2022 02:47 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 1,600 | $13.67 | $21,872.00 |
DisclosureSEC source: 0001654954-22-000543 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 489,247 F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. This does not represent a sale by the Reporting Person. Read SEC document |
| December 21, 2021 Filed Dec 22, 2021 23:11 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GiftCommon Stock | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-013458 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 490,847 F1 · shares: The shares were donated to Schwab Charitable. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 21:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 10,344 | $0.00 Strike: $3.93 | $0.00 |
DisclosureSEC source: 0001654954-21-012199 · section16.xml · derivative · entry 11 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock0 · 10,344 shares Expires 2024-07-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 21:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 19,003 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001654954-21-012199 · section16.xml · derivative · entry 10 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,003 shares Expires 2025-08-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 21:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 29,880 | $0.00 Strike: $2.10 | $0.00 |
DisclosureSEC source: 0001654954-21-012199 · section16.xml · derivative · entry 9 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 29,880 shares Expires 2022-04-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 21:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 15,140 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001654954-21-012199 · section16.xml · derivative · entry 8 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,140 shares Expires 2023-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 21:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 62,727 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001654954-21-012199 · section16.xml · derivative · entry 7 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,338 Underlying: Common Stock · 62,727 shares Expires 2026-07-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 21:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 80,000 | $23.29 | $1,862,960.00 |
DisclosureSEC source: 0001654954-21-012199 · section16.xml · nonDerivative · entry 6 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 499,847 F1 · shares: The shares were sold to cover the exercise cost and income tax payments in connection with the exercise of non-qualified stock options. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.91 to $23.90, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 21:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 62,727 | $1.64 | $102,558.65 |
DisclosureSEC source: 0001654954-21-012199 · section16.xml · nonDerivative · entry 5 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 579,847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 21:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 19,003 | $2.40 | $45,607.20 |
DisclosureSEC source: 0001654954-21-012199 · section16.xml · nonDerivative · entry 4 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 517,120 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 21:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 10,344 | $3.93 | $40,651.92 |
DisclosureSEC source: 0001654954-21-012199 · section16.xml · nonDerivative · entry 3 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 498,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 21:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 15,140 | $1.68 | $25,435.20 |
DisclosureSEC source: 0001654954-21-012199 · section16.xml · nonDerivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 487,773 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 21:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 29,880 | $2.10 | $62,748.00 |
DisclosureSEC source: 0001654954-21-012199 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 472,633 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2021 Filed Nov 8, 2021 23:13 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 100,000 | $25.75 | $2,575,000.00 |
DisclosureSEC source: 0001654954-21-011794 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 442,753 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $26.655, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 14, 2021 Filed Oct 15, 2021 21:01 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 2,391 | $20.69 | $49,469.79 |
DisclosureSEC source: 0001654954-21-011154 · section16.xml · nonDerivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 542,753 F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. This does not represent a sale by the Reporting Person. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 21:01 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 1,515 | $20.46 | $30,996.90 |
DisclosureSEC source: 0001654954-21-011154 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 545,144 F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. This does not represent a sale by the Reporting Person. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 00:58 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | OtherCommon Stock | 1,814 | $2.18 | $3,962.68 |
DisclosureSEC source: 0001654954-21-010775 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 546,659 F1 · shares: These shares have been purchased through the Company's Amended and Restated 2006 Employee Stock Purchase Plan, a "tax-conditioned plan" per Internal Revenue Code Section 423. This purchase is exempt from Section 16 of the Securities Exchange Act of 1934 regarding liabilities arising from six-month short-swing transactions in the Company's securities. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| September 28, 2021 Filed Sep 30, 2021 20:01 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 206,567 | $14.19 | $2,931,185.73 |
DisclosureSEC source: 0001654954-21-010600 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 544,845 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.50 to $14.79, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| August 13, 2021 Filed Aug 16, 2021 17:28 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionIncentive Stock Option (Right to Buy) · Derivative | 62,310 | $0.00 Strike: $2.71 | $0.00 |
DisclosureSEC source: 0001654954-21-009027 · section16.xml · derivative · entry 3 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62,310 shares Expires 2021-08-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| August 13, 2021 Filed Aug 16, 2021 17:28 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 62,310 | $2.71 | $168,860.10 |
DisclosureSEC source: 0001654954-21-009027 · section16.xml · nonDerivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 751,412 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| August 12, 2021 Filed Aug 16, 2021 17:28 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 17,000 | $5.78 | $98,260.00 |
DisclosureSEC source: 0001654954-21-009027 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 689,102 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.75 to $5.83, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. Read SEC document |
| August 03, 2021 Filed Aug 4, 2021 00:05 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 37,690 | $0.00 Strike: $2.71 | $0.00 |
DisclosureSEC source: 0001654954-21-008454 · section16.xml · derivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,690 shares Expires 2021-08-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| August 03, 2021 Filed Aug 4, 2021 00:05 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 37,690 | $2.71 | $102,139.90 |
DisclosureSEC source: 0001654954-21-008454 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 706,102 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| July 14, 2021 Filed Jul 15, 2021 22:15 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 1,395 | $2.83 | $3,947.85 |
DisclosureSEC source: 0001654954-21-007988 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 668,412 F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. This does not represent a sale by the Reporting Person. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| July 13, 2021 Filed Jul 14, 2021 20:29 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 51,741 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-007930 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 669,807 F1 · shares: One-sixteenth (1/16) of the total number of shares subject to the restricted stock unit awards shall become exercisable at the end of each three full calendar months following the date of this action, provided that such recipient is still employed by the corporation on such dates. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| July 06, 2021 Filed Jul 7, 2021 20:45 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 9,668 | $2.50 | $24,170.00 |
DisclosureSEC source: 0001654954-21-007703 · section16.xml · nonDerivative · entry 3 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 618,066 F3 · shares: Represents shares withheld by the Issuer to satisfy tax withholding and remittance obligation in connection with the transactions described in footnote 1 and footnote 2. This does not represent a sale by the Reporting Person. Read SEC document |
| July 06, 2021 Filed Jul 7, 2021 20:45 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 6,690 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-007703 · section16.xml · nonDerivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 627,734 F2 · shares: Represents shares of common stock issued for bonus. Read SEC document |
| July 06, 2021 Filed Jul 7, 2021 20:45 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 17,326 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-007703 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 621,044 F1 · shares: RSU shares issued in lieu of cash for the restoration of 30% salary deduction for the six months ended May 31, 2021. Read SEC document |
| April 16, 2021 Filed Apr 20, 2021 19:52 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 993 | $2.18 | $2,164.74 |
DisclosureSEC source: 0001654954-21-004404 · section16.xml · nonDerivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 603,718 F2 · shares: Represents shares withheld by the Issuer to satisfy tax withholding and remittance obligation in connection with the bonus described in footnote 1. This does not represent a sale by the Reporting Person. Read SEC document |
| April 16, 2021 Filed Apr 20, 2021 19:52 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 3,440 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-004404 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 604,711 F1 · shares: Represents shares of common stock issued for bonus. Read SEC document |
| April 14, 2021 Filed Apr 15, 2021 01:37 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 1,615 | $2.26 | $3,649.90 |
DisclosureSEC source: 0001654954-21-004183 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 601,271 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding and remittance obligation in connection with the vesting of restricted stock units award, which was originally reported by the Reporting Person in Form 4 filed on July 15, 2020. This does not represent a sale by the Reporting Person. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 20:06 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | OtherCommon stock | 2,661 | $1.14 | $3,030.88 |
DisclosureSEC source: 0001654954-21-003819 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 602,886 F1 · shares: These shares have been purchased through the Company's Amended and Restated 2006 Employee Stock Purchase Plan, a "tax-conditioned plan" per Internal Revenue Code Section 423. This purchase is exempt from Section 16 of the Securities Exchange Act of 1934 regarding liabilities arising from six-month short-swing transactions in the Company's securities. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.